Related topics

Aimmune Therapeutics: 3Q Earnings Snapshot

November 6, 2019

BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Wednesday reported a loss of $64.5 million in its third quarter.

The Brisbane, California-based company said it had a loss of $1.03 per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.01 per share.

Aimmune Therapeutics shares have increased 19% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $28.57, a drop of almost 6% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AIMT at https://www.zacks.com/ap/AIMT